hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 20:51:45 - browse：3

ADAM FEUERSTEIN/STAT

CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701 with the potential to be better tolerated than Padcev, an ADC treatment bladder cancer that Pfizer acquired as part of its $43 billion Seagen deal.

On Saturday, Corbus updated results from an early, dose-finding study of CRB-701, showing an overall response rate of 28% from 25 evaluable patients. Closer attention is being paid to the subset of 15 patients treated at three therapeutically active doses, where the overall response rate (all partial tumor shrinkage) was 40%. All of the responses were seen in bladder cancer (where Padcev is approved) and in cervical cancer.

The data, from a study conducted in China, were presented in a poster session at the annual meeting of the American Society of Clinical Oncology.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： 2 US Navy sailors arrested for allegedly spying for China

focus

hotspot

WSS

White House drug shortage group privately met with industry

Medicare Advantage insurers pressure Biden for bigger payments

With Wegovy coverage, Medicare patients may face high costs

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Erich Jarvis studies song birds to learn about human stuttering

What the cancer research community can learn from the Covid response

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Heart attack and stroke risk calculators need revising

Yancopoulos of Regeneron works to expand Dupixent success

Medical records are filled with copy

Dramatically reducing cancer deaths requires the PASTEUR Act

Peter Hotez and the public health issue of online harassment

Adam's Take: Intra

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Microsoft strikes partnership with Duke Health to advance health AI

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ER docs worry over extreme heat as a 'mass casualty event'

explore

ER docs worry over extreme heat as a 'mass casualty event'

Biotech investment managers search for lucrative opportunities

What the cancer research community can learn from the Covid response

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Pfizer, Moderna say biotech, pharma drug development is a sprint

Yancopoulos of Regeneron works to expand Dupixent success

focus

entertainment

hotspot

leisure time